216 related articles for article (PubMed ID: 20884433)
21. Combined distal embolization protection and rheolytic thrombectomy to facilitate percutaneous revascularization of totally occluded saphenous vein grafts.
Gaitonde RS; Sharma N; von der Lohe E; Kalaria VG
Catheter Cardiovasc Interv; 2003 Oct; 60(2):212-7. PubMed ID: 14517927
[TBL] [Abstract][Full Text] [Related]
22. Revitalizing embolic protection in saphenous vein grafts.
Satler LF
Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
[No Abstract] [Full Text] [Related]
23. Embolic protection devices in saphenous vein graft interventions.
Cragun DT; Heuser RR
J Interv Cardiol; 2006 Dec; 19(6):525-9. PubMed ID: 17107367
[TBL] [Abstract][Full Text] [Related]
24. Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts.
Kurowski V; Toelg R; Jain D; Richter C; Wiegand UK; Richardt G; Khattab AA
Am J Cardiol; 2005 Sep; 96(5):681-4. PubMed ID: 16125495
[TBL] [Abstract][Full Text] [Related]
25. Beyond embolic protection for saphenous vein graft disease.
Satler LF
Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
[No Abstract] [Full Text] [Related]
26. The use of drug-eluting stents in venous coronary artery bypass grafts.
Hernandez-Antolín R; Alfonso F; Jimenez P
EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous intervention on the saphenous vein bypass grafts--long-term outcomes.
Bansal D; Muppidi R; Singla S; Sukhija R; Zarich S; Mehta JL; Sachdeva R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):58-61. PubMed ID: 18098183
[TBL] [Abstract][Full Text] [Related]
28. Coronary Artery Tenting After Bypass Grafting: A Key Issue During Percutaneous Coronary Intervention of a Chronic Total Occlusion.
Jurado-Román A; Rumoroso JR; Abellán-Huerta J; López-Lluva MT; Sánchez-Pérez I; Ruíz-Poveda FL
J Invasive Cardiol; 2019 Jan; 31(1):E2-E3. PubMed ID: 30611126
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.
Stone GW; Rogers C; Hermiller J; Feldman R; Hall P; Haber R; Masud A; Cambier P; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA;
Circulation; 2003 Aug; 108(5):548-53. PubMed ID: 12874191
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent.
Gurbel PA; Criado FJ; Curnutte EA; Patten P; Secada-Lovio J
Cathet Cardiovasc Diagn; 1997 Jan; 40(1):75-8. PubMed ID: 8993819
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous intervention over the origin of a saphenous vein graft anastomosed with the St. Jude Medical Symmetry Aortic Connector System.
Fuertes J; Lozano I; Turiel JM; Llosa JC; Suarez E; de la Tassa CM
Catheter Cardiovasc Interv; 2004 Jan; 61(1):103-6. PubMed ID: 14696167
[TBL] [Abstract][Full Text] [Related]
32. Treatment alternatives for chronically occluded saphenous vein grafts.
Heuser RR
J Invasive Cardiol; 1995 May; 7(4):94-6. PubMed ID: 10158110
[No Abstract] [Full Text] [Related]
33. [Postoperative percutaneous coronary angioplasty for stenosed aortocoronary vein bypass].
Otake H; Tanaka N; Mukai K; Fujii S; Michishita I; Shibazaki Y; Genda A; Iwa T
Kyobu Geka; 1991 Oct; 44(11):900-5. PubMed ID: 1942680
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
Bansal D; Sachdeva R; Mehta JL
J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
[No Abstract] [Full Text] [Related]
35. Totally occluded saphenous vein graft recanalization: a dangerous option.
Londero HF
Catheter Cardiovasc Interv; 2003 Oct; 60(2):218-20. PubMed ID: 14517928
[No Abstract] [Full Text] [Related]
36. Treatment of post-stenotic saphenous vein graft aneurysm: special considerations with the polytetrafluoroethylene-covered stent.
Ho PC; Leung CY
J Invasive Cardiol; 2004 Oct; 16(10):604-5. PubMed ID: 15505363
[TBL] [Abstract][Full Text] [Related]
37. Retrograde fractional flow reserve and recanalization of a chronic total occlusion of a saphenous venous graft.
Singla S; Uretsky BF; Sachdeva R
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1210-5. PubMed ID: 22121036
[TBL] [Abstract][Full Text] [Related]
38. Crossover from radial to femoral access during a challenging percutaneous coronary intervention can make the difference between success and failure.
Cooper L; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(4):266.e5-8. PubMed ID: 20934669
[TBL] [Abstract][Full Text] [Related]
39. Comparison of creatine kinase elevation and outcome of comparison of percutaneous coronary intervention for saphenous vein graft in-stent restenosis versus de novo stenosis.
Wolfram R; Leborgne L; Cheneau E; Pichard A; Satler L; Kent K; Waksman R
Am J Cardiol; 2003 Oct; 92(8):980-3. PubMed ID: 14556879
[TBL] [Abstract][Full Text] [Related]
40. Immediate evidence of the benefit of distal protection in vein graft intervention.
Porto I; Cautilli G; Camaioni C
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):828-9. PubMed ID: 21670703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
